Cision PR Newswire

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept....

Searce Wins 2025 Google Cloud Country Partner of the Year for SEA

In collaboration with Google Cloud, Searce co-innovates with clients to futurify their businesses across the SEA region SINGAPORE, April 9, 2025 /PRNewswire/ --...

ATFX Q2 2025 Trader Magazine: Adapting to Global Uncertainty

HONG KONG, April 9, 2025 /PRNewswire/ -- Global markets face heightened volatility in Q2 2025, with economic warfare, inflation, and shifting trade policies creating...

Trina Storage Launches Elementa 2 Pro Energy Storage Solution, Advancing Global Energy Transition

MUNICH, April 9, 2025 /PRNewswire/ -- Trina Storage, a global leader in energy storage solutions, has successfully introduced its latest innovation, the Elementa 2...